News
The Greenlight Capital funds returned 8.2% 1 in the first quarter of 2025, net of fees and expenses, compared to -4.3% for ...
For the first quarter of 2025, a Class A investment in Laughing Water Capital returned approximately -13%. Over the same ...
Decibel Cannabis is poised for a revaluation as it returns to growth in 2025, according to a new report from Ventum Capital ...
JDP Capital Management, an investment management company, released its “Survivor & Thriver Fund” first quarter 2025 investor ...
Letter outlines Phase 3 timeline for PrimeC in ALS, provides update on Canadian regulatory pathway and strategic partnership discussions; Company optimistic about ongoing ...
Despite a forward P/E of 83.1x, Tesla’s high valuation, mixed analyst sentiment, and insider selling suggest holding current ...
Today, judges at the Senior Special Judges' Court are scheduled to examine the charge sheet against Ms Siddiq, 42, and issue an arrest warrant for her.
The arrest warrant came after Bangladesh's Anti-Corruption Commission (ACC) submitted a criminal charge sheet against the ...
Besides generics, Dr. Reddy’s has committed a lot of resources to develop its biosimilars as well as new chemical entity business. Biosimilars have been seen as a growth engine for large, capable ...
While many investors have been scared away from tech giants at the center of this year’s equity rout, the companies are ...
However, elsewhere sufficient subprime mortgages remained on intermediary bank balance sheets (including that of Merrill Lynch where I then worked), to sink a few investment banks and trigger the ...
Opinion
Askeladden Capital Management LLC: Askeladden Capital Comments on AstroNova Q4 and FY2025 ResultsQ4 represents fourth consecutive quarter of poor performance blamed on "delays," which are now expected to continue into FY2026ALOT shares are down >50% since the disastrous MTEX acquisition last May, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results